BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 24231306)

  • 1. BVA position on canine fertility services.
    Loeb J
    Vet Rec; 2023 Oct; 193(8):300. PubMed ID: 37861155
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the contrasts: in-depth analysis of human and canine mammary tumors - discoveries at the frontier.
    Gherman LM; Tomuleasa D; Cismaru A; Nutu A; Berindan-Neagoe I
    Med Pharm Rep; 2024 Apr; 97(2):132-142. PubMed ID: 38746025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of Canine Tumours and the Value of Combined Detection of VEGF, P53, SF and NLRP3 for the Early Diagnosis of Canine Mammary Carcinoma.
    Yang NY; Zheng HH; Yu C; Ye Y; Xie GH
    Animals (Basel); 2024 Apr; 14(9):. PubMed ID: 38731276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Importance of Ultrasonography in the Evaluation of Mammary Tumors in Bitches.
    Feliciano MAR; de Miranda BDSP; Aires LPN; Lima BB; de Oliveira APL; Feliciano GSM; Uscategui RAR
    Animals (Basel); 2023 May; 13(11):. PubMed ID: 37889644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of mast cell density, microvascular density and endothelial area with clinicopathological parameters and prognosis in canine mammary gland carcinomas.
    Sakalauskaitė S; Riškevičienė V; Šengaut J; Juodžiukynienė N
    Acta Vet Scand; 2022 Jun; 64(1):14. PubMed ID: 35761297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative near-infrared imaging can identify canine mammary tumors, a spontaneously occurring, large animal model of human breast cancer.
    Newton A; Predina J; Mison M; Runge J; Bradley C; Stefanovski D; Singhal S; Holt D
    PLoS One; 2020; 15(6):e0234791. PubMed ID: 32555698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.
    Markkanen E
    Front Cell Dev Biol; 2019; 7():348. PubMed ID: 31921858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells.
    Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL
    Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current biomarkers of canine mammary tumors.
    Kaszak I; Ruszczak A; Kanafa S; Kacprzak K; Król M; Jurka P
    Acta Vet Scand; 2018 Oct; 60(1):66. PubMed ID: 30373614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.
    Carvalho MI; Silva-Carvalho R; Pires I; Prada J; Bianchini R; Jensen-Jarolim E; Queiroga FL
    Biomed Res Int; 2016; 2016():4917387. PubMed ID: 28053982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
    Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
    J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine mammary tumours, an overview.
    Sleeckx N; de Rooster H; Veldhuis Kroeze EJ; Van Ginneken C; Van Brantegem L
    Reprod Domest Anim; 2011 Dec; 46(6):1112-31. PubMed ID: 21645126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
    Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
    Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):175-83. PubMed ID: 24231306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.
    Sleeckx N; Van Brantegem L; Fransen E; Van den Eynden G; Casteleyn C; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2013 May; 148(4):307-17. PubMed ID: 23123127
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.